
Opinion|Podcasts|October 1, 2024
Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations
Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD
2
Evaluating Clinical and Real-World Evidence in Hypercortisolism
3
Interstitial Lung Abnormalities: Recognition, Risk Stratification, and When to Act
4
Management Strategies for Hypercortisolism
5
























































































